RTI International, Research Triangle Park, NC, USA.
US Food and Drug Administration, Silver Spring, MD, USA.
Patient Educ Couns. 2020 Sep;103(9):1724-1735. doi: 10.1016/j.pec.2020.03.018. Epub 2020 Mar 20.
Oncology clinical trials use a variety of clinical endpoints. Patients' understanding of the differences between clinical endpoints is important because misperceptions of treatment efficacy may affect treatment decisions. The objective of this literature review is to find and synthesize available empirical publications assessing patients' understanding of common oncology clinical endpoints.
We conducted a literature search of 5 databases and 3 conferences, limiting the search to articles and abstracts published in English through September 2018. We reviewed the titles and abstracts for inclusion, then reviewed full texts to determine if they reported empirical research studies focused on (1) clinical endpoints, (2) oncology, and (3) patient understanding. The original search identified 497publications, of which 13 met the inclusion criteria.
Available literature yields little information on this topic.The few publications that do exist suggest that healthcare professionals and cancer patients generally do not discuss clinical endpoint concepts and that patients can be confused about the purpose of a treatment based on misperceptions about endpoints.
Research is needed on how to discuss oncology clinical endpoints with patients.
Patient-friendly definitions of clinical endpoints may help healthcare providers communicate important information about treatments to patients.
肿瘤学临床试验使用各种临床终点。患者对临床终点之间差异的理解非常重要,因为对治疗效果的误解可能会影响治疗决策。本文献综述的目的是找到并综合评估患者对常见肿瘤学临床终点理解的现有实证文献。
我们对 5 个数据库和 3 次会议进行了文献检索,仅检索了截至 2018 年 9 月以英文发表的文章和摘要。我们对纳入的标题和摘要进行了审查,然后对全文进行了审查,以确定它们是否报告了专注于以下三个方面的实证研究:(1)临床终点;(2)肿瘤学;(3)患者理解。原始搜索确定了 497 篇出版物,其中 13 篇符合纳入标准。
现有文献对这个主题的信息很少。为数不多的现有文献表明,医疗保健专业人员和癌症患者通常不讨论临床终点概念,而且患者可能会因为对终点的误解而对治疗目的感到困惑。
需要研究如何与患者讨论肿瘤学临床终点。
临床终点的患者友好型定义可能有助于医疗保健提供者向患者传达有关治疗的重要信息。